Mechanisms underlying linear ubiquitination and implications in tumorigenesis and drug discovery

• Published in: Cell communication and signaling 2023-11, Vol.21 (1), p.340-340, Article 340
• Main Authors: Li, Jack, Liu, Sijin, Li, Shitao
• Format: Article
• Language: English
• Subjects: Apoptosis; Cancer; Carcinogenesis; Cell Transformation, Neoplastic; Drug Discovery; Enzymes; Humans; Inflammation; Kinases; Linear ubiquitination, LUBAC; Liver cancer; Lymphoma; Molecular modelling; Neoplasms; NF-kappa B - metabolism; NF-κB; NF-κB protein; Pathogenesis; Phosphorylation; Proteins; Regulation; Review; Signal transduction; T cell receptors; Tumorigenesis; Ubiquitin; Ubiquitin - metabolism; Ubiquitin-Protein Ligases - metabolism; Ubiquitination
• ISSN: 1478-811X; 1478-811X
• DOI: 10.1186/s12964-023-01239-5

Linear ubiquitination is a distinct type of ubiquitination that involves attaching a head-to-tail polyubiquitin chain to a substrate protein. Early studies found that linear ubiquitin chains are essential for the TNFα- and IL-1-mediated NF-κB signaling pathways. However, recent studies have discovered at least sixteen linear ubiquitination substrates, which exhibit a broader activity than expected and mediate many other signaling pathways beyond NF-κB signaling. Dysregulation of linear ubiquitination in these pathways has been linked to many types of cancers, such as lymphoma, liver cancer, and breast cancer. Since the discovery of linear ubiquitin, extensive effort has been made to delineate the molecular mechanisms of how dysregulation of linear ubiquitination causes tumorigenesis and cancer development. In this review, we highlight newly discovered linear ubiquitination-mediated signaling pathways, recent advances in the role of linear ubiquitin in different types of cancers, and the development of linear ubiquitin inhibitors. Video Abstract.